Codes / ICD10CM / M11.0

M11.0 Hydroxyapatite deposition disease

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Hydroxyapatite deposition disease

Summary

Hydroxyapatite deposition disease (HADD) is a condition characterized by the deposition of calcium phosphate crystals (hydroxyapatite) in soft tissues, often leading to inflammation and pain. It commonly affects the shoulder, but other joints may be involved. The condition is typically acute and self-limiting but can cause significant discomfort.

Causes

HADD is caused by the deposition of hydroxyapatite crystals in tendons, ligaments, or bursae. The exact trigger for crystal formation is not fully understood, but it may occur spontaneously or in association with trauma, overuse, or metabolic conditions. The crystals can provoke an inflammatory response, leading to symptoms.

Risk Factors

  • Repetitive shoulder motion or overuse.
  • Trauma to the affected joint.
  • Metabolic disorders (e.g., diabetes, hyperparathyroidism).
  • Advanced age.
  • Chronic kidney disease.

Symptoms

  • Sudden, severe pain in the affected joint (often the shoulder).
  • Swelling and tenderness.
  • Limited range of motion.
  • Warmth or redness over the joint.
  • Pain that worsens with movement.

Diagnosis

Diagnosis is based on clinical presentation, including sudden onset of pain and tenderness in a joint. Imaging (e.g., X-rays, ultrasound) may show calcific deposits. Joint aspiration is rarely performed but can reveal hydroxyapatite crystals under polarized light microscopy. Blood tests may rule out other inflammatory conditions.

Treatment Options

  • Rest and Immobilization: Limiting movement to reduce pain and inflammation.
  • Pain Management: Nonsteroidal anti-inflammatory drugs (NSAIDs) or corticosteroid injections.
  • Physical Therapy: Gradual rehabilitation to restore mobility once acute symptoms subside.
  • Heat or Cold Therapy: To alleviate discomfort.

Prognosis and Follow-Up

Most cases resolve spontaneously within weeks to months with conservative treatment. Recurrence is possible, especially with repeated trauma or overuse. Follow-up may involve monitoring for persistent symptoms or complications, such as chronic pain or reduced function.

Complications

  • Chronic pain or stiffness if inflammation persists.
  • Reduced joint mobility due to scarring or calcification.
  • Rarely, calcific tendinitis may lead to tendon rupture.

Lifestyle & Prevention

  • Avoid repetitive overhead motions or heavy lifting.
  • Maintain good posture and joint health.
  • Use ergonomic tools or techniques during activities.
  • Gradually increase activity levels to prevent overuse.

When to Seek Professional Help

Seek medical attention if pain is severe, unrelenting, or accompanied by fever, swelling, or inability to move the joint. Persistent symptoms after initial treatment may require further evaluation to rule out other conditions.

Tips for Medical Coders

Document the affected joint (e.g., shoulder) and clinical findings (e.g., acute pain, calcific deposits on imaging) to support the diagnosis. Ensure the code M11.0 is used for hydroxyapatite deposition disease without specifying a laterality unless documented. Avoid coding for unrelated conditions or complications unless explicitly noted.

Book a walkthrough

M11.0 policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.